Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

cancer therapeutics Market Research Reports

Titlepublishedprice

China Non-Hodgkin Lymphoma Therapeutics Market Report & Forecast 2021-2027

By QYResearch Group
"...... pplication, 2016-2021, 2022-2027 ($ Millions) China Non-Hodgkin Lymphoma Therapeutics Market Segment Percentages, By Application, 2020 (%) - Clinical Research - Treatment Competitor Analysis The report also ......"
16-Nov-2021$3400

China Melanoma Therapeutics Market Report & Forecast 2021-2027

By QYResearch Group
"...... noma Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Melanoma Therapeutics Market Segment Percentages, By Application, 2020 (%) - Hospitals - Clinics - Others Competitor Analysis......"
15-Nov-2021$3400

China Acute Lymphoblastic Leukemia Therapeutics Market Report & Forecast 2021-2027

By QYResearch Group
"...... plantation China Acute Lymphoblastic Leukemia Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Acute Lymphoblastic Leukemia Therapeutics Market Segment Percentages, By Application, 2020 (%) - H......"
02-Nov-2021$3400

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.Acute lymphocytic leukemia (ALL) is the cancer of the white blood cells due to the production of a large number of immature lymphocytes thus blocking the production of normal blood cells......"
31-Oct-2021$2500

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... Leukemia (Oncology) pipeline landscape.Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms usually develop slowly. Symptoms of CLL inc......"
31-Oct-2021$2500

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... the Chronic Myelocytic Leukemia (Oncology) pipeline landscape.Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. Risk facto......"
31-Oct-2021$2000

Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... landscape.Non-Hodgkin lymphoma (also known as non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body's immune system. Symptoms depend on what area of the body is affect......"
31-Oct-2021$2500

Chondrosarcoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... arcoma is a malignant cancer whose tumor cells produce a pure hyaline cartilage that results in abnormal bone and/or cartilage growth. Signs and symptoms include pain in the affected area that may worsen at night or during physical activity, swelling......"
31-Oct-2021$2000

Ewing Sarcoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... /> Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but usually develops during puberty, when bones are growing rapidly. There are few symp......"
31-Oct-2021$2000

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct
"...... eline landscape.Anaplastic astrocytoma is a grade III tumor. It accounts for two percent of all brain tumors. It is a type of glioma that develops from star-shaped glial cells (astrocytes), which support nerve cells. Anaplastic astrocytoma grows fast......"
31-Oct-2021$2000

Buy Any Report Avail 20% Discount. Coupon Code: NOV20

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy